Companies in #Kidney Disease
Found 3 companies operating in this sector.
Mission Therapeutics
PrivateUK-based drug discovery and development company focused on selective mitophagy modulation through USP30 inhibition for CNS and kidney disease.
Unicycive Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for kidney diseases, including phosphate-binding agents for hyperphosphatemia in chronic kidney disease and dialysis patients.
Vera Therapeutics is a late-stage clinical biopharmaceutical company developing treatments for serious immunological diseases. Its lead asset atacicept (a dual BAFF/APRIL inhibitor) received FDA approval in 2026 for IgA nephropathy (IgAN), establishing it as the first-in-class targeted therapy for this kidney disease.